NCT00129571View on ClinicalTrials.gov

Study of XL820 in Adults With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2005

Conditions

Cancer

Interventions

DRUG

XL820

Trial Locations (2)

78229

Cancer Therapy and Research Center, San Antonio

08901

The Cancer Institute of New Jersey, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Exelixis

INDUSTRY